Bradley & Co Private Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bradley & Co Private Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.2K	Hold	100	–	–	0.01%	121
2026 Q1	$19.6K	Hold	100	–	–	0.01%	116
2025 Q4	$17.4K	Hold	100	–	–	0.01%	118
2025 Q3	$19.1K	Hold	100	–	–	0.01%	111
2025 Q2	$18K	Hold	100	–	–	0.01%	107
2025 Q1	$16.9K	Hold	100	–	–	0.01%	109
2024 Q4	$15.1K	Buy	+100	New	+$15.6K	0.01%	110
2024 Q2	$13.7K	Hold	100	–	–	0.01%	108
2024 Q1	$13.3K	Hold	100	–	–	0.01%	112
2023 Q4	$13.8K	Hold	100	–	–	0.01%	112
2023 Q3	$12.2K	Hold	100	–	–	0.01%	108
2023 Q2	$14.1K	Hold	100	–	–	0.01%	108
2023 Q1	$14.1K	Hold	100	–	–	0.02%	109
2022 Q4	$15.6K	Hold	100	–	–	0.02%	106
2022 Q3	$12K	Hold	100	–	–	0.01%	120
2022 Q2	$13K	Hold	100	–	–	0.01%	128
2022 Q1	$14K	Hold	100	–	–	0.01%	121
2021 Q4	$17K	Hold	100	–	–	0.01%	124
2021 Q3	$15K	Hold	100	–	–	0.01%	129
2021 Q2	$13K	Hold	100	–	–	0.01%	132
2021 Q1	$13K	Buy	+100	New	+$12.3K	0.01%	134

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Bradley & Co Private Wealth Management's DGX Position: Q2 2026 in Review

Bradley & Co Private Wealth Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 100 shares worth $21.2K. The position accounts for 0.01% of the portfolio, ranked #121.

Bradley & Co Private Wealth Management first reported a position in DGX in Q1 2021 and has held it in 21 quarters since. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Bradley & Co Private Wealth Management held 100 shares of Quest Diagnostics worth $21.2K as of Q2 2026.
Bradley & Co Private Wealth Management left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.01% of Bradley & Co Private Wealth Management's portfolio in Q2 2026, its #121 holding.
Bradley & Co Private Wealth Management first reported a position in Quest Diagnostics in Q1 2021 and has held it in 21 quarters since.
1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Bradley & Co Private Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.